10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 316 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $7 | -83.7% | 177 | -85.0% | 0.00% | -85.7% |
| Q4 2023 | $43 | +10.3% | 1,178 | +68.3% | 0.01% | -12.5% |
| Q2 2023 | $39 | 0.0% | 700 | 0.0% | 0.01% | -11.1% |
| Q1 2023 | $39 | -99.4% | 700 | +1527.9% | 0.01% | +800.0% |
| Q4 2021 | $6,000 | 0.0% | 43 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $6,000 | -25.0% | 43 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $8,000 | +14.3% | 43 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | -89.9% | 43 | -91.9% | 0.00% | -83.3% |
| Q3 2020 | $69,000 | – | 532 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 2,106,757 | $117,894,122 | 100.00% |
| Blue Water Life Science Advisors, LP | 194,500 | $10,884,220 | 9.53% |
| Sands Capital Ventures, LLC | 481,770 | $26,959,849 | 7.50% |
| Meritech Capital Associates V L.L.C. | 494,236 | $27,657,447 | 6.73% |
| Decheng Capital LLC | 359,554 | $20,120,642 | 5.62% |
| Iron Triangle Partners LP | 479,374 | $26,825,769 | 3.47% |
| Brown Capital Management | 3,527,297 | $197,387,540 | 2.96% |
| Freshford Capital Management, LLC | 305,798 | $17,112,456 | 2.78% |
| SVB WEALTH LLC | 1,446,552 | $80,949,066 | 1.97% |
| Capital Impact Advisors, LLC | 23,594 | $1,320,320 | 1.74% |